Cognex Corporation (NASDAQ:CGNX) Director Jeffrey Benjamin Miller sold 7,500 shares of the business’s stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $124.23, for a total value of $931,725.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Cognex Corporation (NASDAQ CGNX) opened at $132.88 on Monday. Cognex Corporation has a 12-month low of $49.91 and a 12-month high of $134.70. The firm has a market capitalization of $11,505.63, a PE ratio of 49.03 and a beta of 1.48.

Cognex Corporation’s stock is set to split on the morning of Monday, December 4th. The 2-1 split was announced on Monday, October 30th. The newly created shares will be distributed to shareholders after the closing bell on Friday, December 1st.

Cognex Corporation (NASDAQ:CGNX) last posted its quarterly earnings data on Monday, October 30th. The scientific and technical instruments company reported $1.14 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.09. Cognex Corporation had a return on equity of 23.31% and a net margin of 34.77%. The business had revenue of $259.74 million during the quarter, compared to analysts’ expectations of $255.95 million. During the same quarter in the previous year, the firm earned $0.61 EPS. The firm’s revenue was up 75.6% compared to the same quarter last year. equities research analysts anticipate that Cognex Corporation will post 2.77 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 1st. Investors of record on Friday, November 17th will be given a dividend of $0.09 per share. This represents a $0.36 annualized dividend and a dividend yield of 0.27%. The ex-dividend date of this dividend is Thursday, November 16th. This is a boost from Cognex Corporation’s previous quarterly dividend of $0.09. Cognex Corporation’s payout ratio is currently 12.55%.

ILLEGAL ACTIVITY WARNING: “Cognex Corporation (CGNX) Director Sells $931,725.00 in Stock” was first reported by Watch List News and is owned by of Watch List News. If you are accessing this report on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The legal version of this report can be viewed at https://www.watchlistnews.com/cognex-corporation-cgnx-director-sells-931725-00-in-stock/1682054.html.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. BlackRock Inc. lifted its position in shares of Cognex Corporation by 3.5% during the 2nd quarter. BlackRock Inc. now owns 6,887,038 shares of the scientific and technical instruments company’s stock worth $584,711,000 after purchasing an additional 231,014 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of Cognex Corporation by 2.4% during the 2nd quarter. Vanguard Group Inc. now owns 6,734,216 shares of the scientific and technical instruments company’s stock worth $571,735,000 after purchasing an additional 159,355 shares during the last quarter. Ameriprise Financial Inc. lifted its position in shares of Cognex Corporation by 126.7% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,342,312 shares of the scientific and technical instruments company’s stock worth $198,864,000 after purchasing an additional 1,309,047 shares during the last quarter. State Street Corp lifted its position in shares of Cognex Corporation by 2.2% during the 2nd quarter. State Street Corp now owns 2,169,073 shares of the scientific and technical instruments company’s stock worth $184,153,000 after purchasing an additional 45,840 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its position in shares of Cognex Corporation by 21.3% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,261,312 shares of the scientific and technical instruments company’s stock worth $107,085,000 after purchasing an additional 221,545 shares during the last quarter. 86.17% of the stock is owned by institutional investors and hedge funds.

A number of analysts have weighed in on the company. Zacks Investment Research raised Cognex Corporation from a “hold” rating to a “buy” rating and set a $138.00 price target for the company in a research report on Wednesday, November 1st. Canaccord Genuity boosted their price target on Cognex Corporation from $95.00 to $120.00 and gave the stock a “hold” rating in a research report on Tuesday, October 31st. Robert W. Baird boosted their price target on Cognex Corporation from $100.00 to $124.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 31st. Wolfe Research raised Cognex Corporation from a “market perform” rating to an “outperform” rating in a research report on Monday, August 14th. Finally, Cowen and Company reaffirmed an “outperform” rating and issued a $135.00 price target (up previously from $100.00) on shares of Cognex Corporation in a research report on Tuesday, August 8th. Five investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company’s stock. Cognex Corporation presently has a consensus rating of “Buy” and an average price target of $99.50.

Cognex Corporation Company Profile

Cognex Corporation (Cognex) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company operates through the machine vision technology segment. The Company’s machine vision products are used to automate the manufacture and tracking of discrete items, such as mobile phones, aspirin bottles and automobile tires, by locating, identifying, inspecting and measuring them during the manufacturing or distribution process.

Insider Buying and Selling by Quarter for Cognex Corporation (NASDAQ:CGNX)

Receive News & Ratings for Cognex Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.